Your Health, We Care
The specification of Balversa produced by Lucius is 3mg * 28pills, and the current price is $111.
Balversa, as a novel oral anticancer drug, has shown significant efficacy in the treatment of urothelial carcinoma.
Balversa is a small molecule inhibitor of fibroblast growth factor receptor (FGFR) used to treat cancer. It is the first personalized treatment drug for susceptible FGFR gene mutat···【more】
Article source：Lucius LaosRelease date：2024-11-13Recommended：163
Balversa, a new targeted anti-cancer drug, provides new treatment hope for patients with advanced cancer by precisely inhibiting the FGFR signaling pathway.Is Balversaexpensive? Ho···【more】
Article source：Lucius LaosRelease date：2024-08-26Recommended：114
Balversa is a novel targeted anti-cancer drug that inhibits the FGFR signaling pathway for the treatment of advanced cancer, providing patients with precision treatment options and···【more】
Article source：Lucius LaosRelease date：2024-08-26Recommended：92
Balversais an oral, targeted anti-cancer drug that specifically inhibits the FGFR signaling pathway and is used to treat specific types of advanced cancers, such as urothelial carc···【more】
Article source：Lucius LaosRelease date：2024-08-26Recommended：107
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
